Interviews, editorial viewpoints and discussions around key news items and their impact on global clinical research. Presented by The Institute of Clinical Research, a leading membership organisation for professionals involved with the design, management, conduct and reporting of clinical trials.
Simon Day is a Statistical Expert at Roche Products, and is both Past President of the International Society for Clinical Biostatistics and Joint Edit...
A new report from Deloitte looks at the decline in Internal Rate of Return (IRR) across pharma R&D, and suggests that improving late stage success rat...
Steve Read is Managing Director of Adair International and the Helix Consultancy. Andrew Smith speaks with him about leadership in business and how pr...
Part one of our three-part interview with Jonathan Sheffield OBE, Chief Executive Officer of the National Institute for Health Research Clinical Resea...
The Academy of Medical Sciences’ review of regulation and governance of clinical research, “A new pathway for the regulation and governance of health ...
The estimate for the cost of bringing a single new medicine successfully to market is generally accepted to be around $1b, based on study data publish...
Andrew Smith and Adam Jacobs discuss the background and implications of news stories from throughout the clinical research community, covering stories...
In May's Viewpoint column, Andrew Smith argues that the globalisation of clinical research requires a new generation of manager, with awareness of glo...